Subscribe to Updates
Subscribe to our newsletter and never miss our latest news
Subscribe my Newsletter for New Posts & tips Let's stay updated
Subscribe to our newsletter and never miss our latest news
Subscribe my Newsletter for New Posts & tips Let's stay updated
Every new boss has a move. Some announce layoffs. Others reorganize the company.Kevin Warsh launched task forces.”At any institution, a change in leadership is a natural and timely opportunity to reaffirm its mission, to review current practices, and to consider whether those practices best meet our objectives,” Warsh said Wednesday during a press conference. “My Fed colleagues and I will be working in close collaboration to ask what changes might improve the conduct of monetary policy.”Warsh has arrived at the Fed as a new appointee of President Donald Trump, following the end of former chair Jerome Powell’s tenure, with experience…
Jeff Bezos predicts AI will do the opposite of what most people fear.Speaking at the VivaTech conference in Paris on Wednesday, the Amazon founder pushed back on growing fears that AI will eliminate large numbers of jobs. Instead, he said that the technology will unlock new opportunities and increase demand for people capable of turning ideas into reality.”I know there’s a lot of concern that many people have, including many smart people, that AI is going to make humans redundant,” Bezos said. “I totally disagree with this point of view, and I think, in fact, AI is going to create…
Disney’s AI ad push is picking up steam.The company is preparing to launch a beta version of a tool for AI-generated TV ads in July, a Disney exec said at an internal meeting, according to an audio recording shared with Business Insider.The entertainment giant originally shared news of the tool in January, as part of a broader CES announcement of upcoming tech-driven features for advertisers. Other major ad sellers, such as Google, Meta, and TikTok, have also rolled out AI ad-generation tools for advertisers.Adam Smith, the chief product and technology officer for Disney Entertainment and ESPN, shared the timing update with…
Kevin Warsh has taken the podium — and he plans to make some major changes at the central bank.The Federal Open Market Committee opted to hold rates steady at its June meeting, the first with former Wall Street executive Warsh as chair. FOMC leaders voted unanimously for the hold, with half predicting at least one rate hike by year’s end.But what stuck out from Warsh’s first press conference wasn’t monetary policy; it was how much he plans to change long-standing Fed traditions.Fewer forecasts, more task forcesWarsh chose to eliminate the Fed’s forward guidance in June’s statement. That statement was bare-bones…
This story is based on an interview with Jackie Crenshaw, 61, of East Haven, Connecticut, the senior manager of breast imaging at a cancer hospital. It has been edited for length and clarity.As I approached my 59th birthday in the summer of 2023, I thought about retiring. I had healthy investments and a robust 401(k) after working a six-figure-salary job for many years and saving about 15% of my income.The prospect of change made me think about having someone to hang out with — a companion to share my later life. Have you been the victim of a romance scam?…
EarnOS, a startup that pays people to interact with brands online to ensure they are seen by humans and not AI bots, has raised $18.5 million in funding.On Wednesday, the New York-based company launched its app, Ero, where customers can verify they are human and earn rewards for engaging with a brand’s content. Users can scroll through the Ero app feed and participate in challenges, such as physical activities tracked through their fitness app, share their data, and click on brand content.Brands only pay when someone engages with them, and the app helps them to ensure humans, and not AI…
When thinking about the hardest schools to get into in the US, your mind might immediately go to the historic brick walls of Ivy League institutions or to schools at the cutting edge of technology, like MIT and Caltech.But there is a tiny music conservatory in Philadelphia that is just as selective as these schools.At the Curtis Institute of Music, which has been operating for over 100 years, fewer than 30 students are admitted each year — and none of them pay tuition.Only 5% of applicants are accepted Outside view of the Curtis Institute building in Philadelphia. Paul Marotta/Getty Images…
A view of a CarMax dealership on April 10, 2025, in Santa Rosa, California.Justin Sullivan | Getty ImagesShares of CarMax fell roughly 8% during midday trading Wednesday after the company beat Wall Street’s quarterly earnings expectations and its new CEO detailed a high-level turnaround strategy for the company.Here’s how the company performed in its first fiscal quarter, compared with average estimates compiled by LSEG:Earnings per share: $1.31 vs. 95 cents expected Revenue: $8.01 billion vs. $7.42 billion expectedDespite the beats, questions remain about the company’s ability to grow and cut costs under the plan as it faces tougher market conditions. The used…
A JetBlue Airlines plane lands near the Air Traffic Control tower at the Fort Lauderdale-Hollywood International Airport on Oct. 7, 2025 in Fort Lauderdale, Florida.Joe Raedle | Getty ImagesJetBlue Airways told CNBC on Wednesday that it will close its flight attendant base at Newark Liberty International Airport in New Jersey and tech operations bases there and at LaGuardia Airport in New York this fall as it seeks to reduce costs and beef up service in Florida, though it noted that no staff will lose their jobs.It said staff could bid or transfer to other bases.”JetBlue is making targeted schedule adjustments,…
Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesUniQure plans to seek FDA approval of its experimental gene therapy for Huntington’s disease, the company said Wednesday, months after previous agency leaders criticized the evidence backing the application. UniQure said the FDA in a recent meeting communicated that a three-year analysis from a Phase 1/2 study would support an accelerated approval of UniQure’s gene therapy for Huntington’s, a rare hereditary disease that gradually destroys nerve cells in the brain. As a result of the meeting, UniQure plans to submit its application to the FDA in the third quarter of this…